Please login to the form below

Not currently logged in
Email:
Password:

ICOs

This page shows the latest ICOs news and features for those working in and with pharma, biotech and healthcare.

Wilmington Healthcare enhances digital platform, McCann recognised at IPA Effectiveness Awards

Courses on offer include What you need to know about NHS England's plan for ICSs and ICOs, which addresses how integrated care systems and integrated care organisations will start to

Latest news

More from news
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • Happy 70th birthday NHS: the next 70 need to be very different Happy 70th birthday NHS: the next 70 need to be very different

    Key to the future of the health service in England will be the Integrated Care Organisations (ICOs), which aim to bring together health and social care services, both to improve patient ... At the moment there are 12 million people in England covered by

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    ICOs (formerly known as Accountable Care Systems) require exceptional individuals who can break down the many institutional, cultural and financial barriers between hospitals, primary care and local authorities.

  • Deal Watch July 2016 Deal Watch July 2016

    It is a humanised inducible co-stimulator (ICOS) agonist antibody, designed to both stimulate T effector cells and selectively reduce intra-tumoural T regulatory cells.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics